A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z    

Froidefond, E.

Paper Title Page
MOPCH108 Error Study of LINAC 4 294
 
  • M.A. Baylac, J.-M. De Conto, E. Froidefond
    LPSC, Grenoble
  • E.Zh. Sargsyan
    CERN, Geneva
 
  Within the framework of the Joint Research Activity HIPPI (High Intensity Pulsed Proton Injector) of the CARE program, the conception study of the LINAC 4 accelerator which aims to intensify the proton flux available for the CERN injection line is pursued. The linac, operating in pulsed mode at 352 MHz, is designed to accelerate a 65 mA beam of H- ions up to an energy of 160 MeV. The requirements on acceptable beam emittance growth and particle loss are extremely tight. In order to determine the Drift Tube Linac tolerances, we examined the sensitivity of the LINAC 4 DTL to errors on the accelerating field and the focusing quadrupoles. Simulations were performed with the transport code TRACEWIN (CEA-Saclay, France). We will present results on individual sensitivities to a single error as well as the global impact of alignment and RF errors on the beam quality. Similarly, accelerating structures following the DTL in the LINAC4 design (CCDTL, SCL) have been studied.  
WEPCH161 The FFAG R&D and Medical Application Project RACCAM 2308
 
  • F. Meot
    CEA, Gif-sur-Yvette
  • B. Autin, J. Collot, J.F. Fourrier, E. Froidefond, F. Martinache
    LPSC, Grenoble
  • J.L. Lancelot, D. Neuveglise
    SIGMAPHI, Vannes
 
  The RACCAM project (Recherche en ACCelerateurs et Applications Medicales) has recently obtained fundings, extending over three years (2006-2008), from the French National Research Agency (ANR). RACCAM is a tripartite collaboration, involving (i) the CNRS Laboratory IN2P3/LPSC, (ii) the French magnet industrial SIGMAPHI, and (iii) the nuclear medecine Departement of Grenoble Hospital. The project concerns fixed field alternating gradient accelerator (FFAG) research on the one hand, and on the other hand their application as hadrontherapy and biology research machines. RACCAM's goal is three-fold, (i) participate to the on-going international collaborations in the field of FFAGs and recent concepts of "non-scaling" FFAGs, with frames for instance, the Neutrino Factory (NuFact) and the EMMA project of an electron model of a muon FFAG accelerator, (ii) design, build and experiment a prototype of an FFAG magnet proper to fulfil the requirements of rapid cycling acceleration, (iii) develop the concepts, and show the feasibility, of the application of such FFAG beams to hadrontherapy and to biology research.

*CEA/DAPNIA and IN2P3/LPSC **IN2P3/LPSC ***Grenoble University Hospital ****SIGMAPHI

 
WEPCH162 Magnet Simulations for Medical FFAG 2310
 
  • E. Froidefond
    LPSC, Grenoble
  • B. Autin
    CERN, Geneva
 
  Studies have been undertaken concerning magnet design in the frame of the RACCAM FFAG project (this conference). This contribution reports on the objectives of the project in that matter, on the working methods and calculation tools developments, magnetic field modeling and simulations, and on the present status of this work.